Navigation Links
Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
Date:7/10/2014

LAVAL, Quebec, July 10, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash, pursuant to the previously announced agreement with Nestle S.A, which recently completed its acquisition of Galderma.

"We are pleased to complete the divestiture of our products to a company that is firmly committed to the aesthetic dermatology market," said J. Michael Pearson, chairman and chief executive officer.  "Humberto Antunes, CEO of Galderma, has embraced our commercial team and I know he will continue our efforts to build strong relationships with the healthcare leaders in this industry."

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Contact Information:

Laurie W. Little
949-461-6002
laurie.little@valeant.com

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
2. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
3. Valeant Pharmaceuticals To Present At Industry Conferences
4. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
5. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
6. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
7. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
8. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
9. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
10. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
11. Valeant Pharmaceuticals Announces Continuance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017 Angel MedFlight Worldwide ... Capt. Mark Kelly as the keynote speaker ... Conference in Washington D.C. April ... speak on Friday morning, April 21 at the Gaylord ... across the country are expected to attend the annual ...
(Date:1/17/2017)... , Jan. 17, 2017  Market Research Future published a ... Devices Market is expected to reach USD 33.6 million during the ... Market Highlights ... The Global Endoscopy Devices Market has been examined as a swiftly ... there is huge demand for endoscopy device in various regions.  The ...
(Date:1/17/2017)... -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating ... ("Anthera" or the "Company") (NASDAQ: ANTH ). Such ... investigation by visiting the firm,s site: www.bgandg.com/anth .   ... officers and/or directors have violated Sections 10(b) and 20(a) of ... ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading audit, tax, and ... its IT Advisory Services practice . Rossi is the third technology consulting leader ... strategic IT guidance grows, and the practice continues to expand.     , Bringing more than ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians ... Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, ... the announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra ...
(Date:1/17/2017)... ... January 17, 2017 , ... Many people make New Year’s resolutions or renew their commitment ... is making it easier for people who want to kick off 2017 with better smiles. ... patients. , These special offers include: , , A new ...
(Date:1/16/2017)... , ... January 17, 2017 , ... ... Bon Pain, an internationally recognized leader in the fast-casual category, announces a hearty ... as the Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & Honey ...
(Date:1/16/2017)... ... January 16, 2017 , ... Gym Source, America’s leading retailer ... showroom in East Hanover, New Jersey. , “We are elated to be opening this ... in-store concept is designed to give clients a seamless and motivating shopping experience.” , ...
Breaking Medicine News(10 mins):